loadpatents
Patent applications and USPTO patent grants for Feng; Gen-Sheng.The latest application filed is for "combination immunotherapies".
Patent | Date |
---|---|
Combination Immunotherapies App 20210346420 - Feng; Gen-Sheng | 2021-11-11 |
Gab1 Involvement In Glucose Homeostasis Regulation By Hepatocytes App 20110067126 - Feng; Gen-Sheng ;   et al. | 2011-03-17 |
Gab1 involvement in glucose homeostasis regulation by hepatocytes Grant 7,794,956 - Feng , et al. September 14, 2 | 2010-09-14 |
Modulators of Shp2 Tyrosine Phosphatase and Their Use in the Treatment of Body Weight Disorders App 20080058431 - Feng; Gen-Sheng ;   et al. | 2008-03-06 |
Gab1 involvement in glucose homeostasis regulation by hepatocytes App 20050183144 - Feng, Gen-Sheng ;   et al. | 2005-08-18 |
Shp-2 tyrosine phosphatase and embryonic stem cell differentiation App 20040043434 - Feng, Gen-Sheng | 2004-03-04 |
NCAGE Code | 4FN97 | FENG GEN-SHENG |
CAGE Code | 4FN97 | FENG, GEN-SHENG |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.